The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Learn more about the combination of two anti-viral drugs (daclatasvir and asunaprevir) developed by Bristol-Myers Squibb Co that has been highly effective and well tolerated among study participants.
Continue reading »The European Medicines Agency will conduct a full assessment of Gilead Science's Hepatitis C therapy.
Continue reading »
If Medicare must absorb the bulk of Sovaldi’s cost, what long term effect will Hepatitis C treatment have on this federally funded program?
Continue reading »
Learn more about the costly advances in Hepatitis C treatment, and the ethical dilemma it now poses for eradicating the virus from infected prisoners.
Continue reading »AbbVie Inc. is one step closer to marketing its two-drug combination for the treatment of Hepatitis C.
Continue reading »
Researchers in Scotland will determine if Vitamin D can have a positive impact on Hepatitis C cure rates when used in combination with currently available treatment therapies. If confirmed, a less expensive method of treatment could emerge.
Continue reading »
How much will treatment cost for the newly approved Hepatitis C drugs? Will patients in developing countries be able to afford it?
Continue reading »More than 2,300 patients from over 25 countries around the world have participated in the six Phase III trials being conducted by AbbVie to treat genotype 1 Hepatitis C virus infection using a regimen containing ABT-450.
Continue reading »Learn about the trial results for faldaprevir, a once-daily hepatitis C virus (HCV) NS3/4A protease inhibitor.
Continue reading »A handy guide to show which drugs are available now and who the top contenders are for an anticipated 2014, interferon-free, Hepatitis C cure.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
